Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mouchabac

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
L'Encephale|January 3, 2013
[Ideational depressive ruminations]S Mouchabac
L'Encephale|November 24, 2011
[Bipolar disorders: role and burden of family caregivers]S Mouchabac
L'Encephale|February 10, 2010
[Severe depression : pharmacological treatments]S Mouchabac
L'Encephale|February 17, 2016
[Placebo effect: clinical, biological and therapeutical involvements in depression]D Gourion, S Mouchabac
L'Encephale|March 10, 2009
[Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to make the decision to resort to an APAP)]I Chéreau, P Gorwood, S Mouchabac
European Psychiatry : the Journal of the Association of European Psychiatrists|May 24, 2017
Anhedonia predicts poor psychosocial functioning: Results from a large cohort of patients treated for major depressive disorder by general practitionersF Vinckier, D Gourion, S Mouchabac
L'Encephale|July 9, 2013
[Etiopathogeny of the delusion of pregnancy using a literature review: Role of hyperprolactinemia and application of the theory of abductive inference]F Levy, S Mouchabac, C S Peretti
L'Encephale|September 14, 2016
[Interest of scopolamine as a treatment of major depressive disorder]A Rigal, S Mouchabac, C S Peretti
L'Encephale|November 15, 2003
[Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city]S Mouchabac, M Ferreri, F Cabanac, et al.
L'Encephale|November 15, 2003
[Residual symptoms after a treated major depressive disorder: a survey among private psychiatrists]S Mouchabac, M Ferreri, F Cabanac, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
L'Encephale|January 3, 2013
[Ideational depressive ruminations]S Mouchabac
L'Encephale|November 24, 2011
[Bipolar disorders: role and burden of family caregivers]S Mouchabac
L'Encephale|February 10, 2010
[Severe depression : pharmacological treatments]S Mouchabac
L'Encephale|February 17, 2016
[Placebo effect: clinical, biological and therapeutical involvements in depression]D Gourion, S Mouchabac
L'Encephale|March 10, 2009
[Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to make the decision to resort to an APAP)]I Chéreau, P Gorwood, S Mouchabac
European Psychiatry : the Journal of the Association of European Psychiatrists|May 24, 2017
Anhedonia predicts poor psychosocial functioning: Results from a large cohort of patients treated for major depressive disorder by general practitionersF Vinckier, D Gourion, S Mouchabac
L'Encephale|July 9, 2013
[Etiopathogeny of the delusion of pregnancy using a literature review: Role of hyperprolactinemia and application of the theory of abductive inference]F Levy, S Mouchabac, C S Peretti
L'Encephale|September 14, 2016
[Interest of scopolamine as a treatment of major depressive disorder]A Rigal, S Mouchabac, C S Peretti
L'Encephale|November 15, 2003
[Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city]S Mouchabac, M Ferreri, F Cabanac, et al.
L'Encephale|November 15, 2003
[Residual symptoms after a treated major depressive disorder: a survey among private psychiatrists]S Mouchabac, M Ferreri, F Cabanac, et al.
Pageof 2